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Mutations in LMNA encoding lamins A and C are associated with at least 10 different degenerative disorders
affecting diverse tissues, collectively called laminopathies. A recent study showed that mis-accumulation of SUN1
underlies the pathology of degenerative features in laminopathies, and concomitantly suggests a gain-of-function
versus a loss-of-function model for the action of lamin A mutants.The nuclear envelope (NE) is a double-layered mem-
brane separating the cell’s genetic material from the
cytoplasm. The outer nuclear membrane (ONM) fuses
with the inner nuclear membrane (INM) around the nu-
clear pore complex and extends to the endoplasmic
reticulum (ER). Right underneath the INM is a layer of
fine meshwork, namely nuclear lamina wherein various
lamins and interacting proteins reside. A group of SUN
(Sad1/UNC-84 homology) domain-containing proteins
anchor to the INM and interact with different lamins,
on the lamina, and nesprins, on the ONM, thus bridging
nucleoskeleton and cytoskeleton. As one of the major
components of the nuclear lamina (Figure 1), lamin A is
firstly synthesized as prelamin A with an extra 18 amino
acids at the C-terminus, which undergo transient isopre-
nylation, methylation, and these residues are finally
removed by proteolytic cleavage [1]. To date, more than
237 LMNA mutations, leading to at least 163 protein
variants, are known to be associated with at least 10 dif-
ferent degenerative disorders, collectively referred to as
laminopathy. Some of these degenerative features are
recapitulated in mice deficient for Lmna or harboring
various Lmna mutations. Homozygous LmnaL530P/L530P
mutation (LmnaΔ9 or Lamin AΔExon9) or loss of prela-
min A-processing metalloproteinase Zmpste24 in mice
phenocopies many of the progeroid features observed in
Hutchinson-Gilford progeria syndrome (HGPS), one of
the most severe forms of laminopathy that are predom-
inantly caused by a 50-amino-acid deletion in prelamin
A (lamin AΔ50 or progerin). Currently, the phenotypes
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reproduction in any medium, provided the orto be attributable to either loss or gain of function of
lamin A mutants.
A recent paper further highlights the gain-of-function
versus loss-of-function model for the action of lamin A in
laminopathies [2]. Chen et al. found that the level of Sun1
protein was up-regulated and mislocalized to Golgi in
Lmna−/− and LmnaΔ9 cells. Although Golgi accumula-
tion of SUN1 was not observed in HGPS cells, the levels
of total and INM-localized SUN1 were significantly up-
regulated and well correlated with the misshapen nucleus,
one of the hallmarks of HGPS fibroblasts and cells from
mouse HGPS models [3,4]. SUN proteins are major com-
ponents of the LINC (Linker of Nucleoskeleton and Cyto-
skeleton) complex, which links the nucleoskeleton and
cytoskeleton, and mediates nucleus positioning. Further in-
vestigation showed that either increased INM-association
of SUN1 in HGPS or its accumulation at Golgi in Lmna
−/− and LmnaΔ9 cells was detrimental, as knocking down
or genetically depleting SUN1 from the mutant cells
largely rescued the misshapen nucleus and increased cell
survival. Although all three mutant cells exhibited altered
nuclear shape, they were virtually different. While loss of
lamin A leads to partial loss of lamin B1 staining on NE,
progerin only caused nuclear herniation in HGPS (see Fig-
ure 1). Consistent with this notion, Sun1 accumulated in
the Golgi apparatus in Lmna−/− cells, but was properly
localized on the NE in HGPS cells. In addition, while the
majority of ectopic Sun1 can successfully anchor to NE,
causing nucleus herniations, ectopic Golgi-orientated Sun1
led to partial loss of NE on the opposing site to the Golgi,
mimicking Lmna null situation, in wild-type cells. Surpris-
ingly, blocking SUN1 transportation from ER or NE
towards Golgi by different small molecules restored the
NE localization of both SUN1 and lamin B1. These data
suggest that although lamin A is not required for the NEThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Summary of different lamin A mutants in human diseases and mouse models. A, Schematic diagram of lamin A/C protein and
post-translational processing of prelamin A. B, Status of lamin A and localization of SUN1 found in mouse models and human diseases.
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SUN1 on NE [5] and thus prevent SUN1 from accumula-
tion at Golgi. Chen et al. and others also showed that far-
nesylated progerin/prelamin A increased the binding
capacity to SUN1 [2,5]. In HGPS, it has been proposed
that altered nuclear shape (herniation) is attributed to the
accumulation of farnesylated progerin on the nuclear lam-
ina as it can be rescued via treatment with farnesyl trans-
ferase inhibitors (FTIs); the rescue of the misshapen
nucleus by reducing prelamin A or progerin from the nu-
clear lamina ameliorates senescence in HGPS cells [6,7]
and progeroid features in progeria mouse models [7-9].
Remarkably, depleting SUN1 increased life spans in Lmna
−/− and LmnaΔ9 mice and knocking down SUN1 in
HGPS cells rescued heterochromatin loss and accelerated
senescence.
The work by Chen et al. implicates a novel molecular
mechanism for the pathogenesis of laminopathies; mean-
while it also raises many unanswered questions. Why
does loss of lamin A delay the turnover of SUN1? What
is the mechanism for the shuffling of SUN1 between
Golgi and ER or NE? How does Golgi-accumulated
SUN1 elicit degenerative phenotypes in tested mouse
models? Why was Golgi-accumulated SUN1 not
observed in HGPS cells? Answering these questions
would help to better understand the molecular mechan-
ism through which laminopathies are rescued by SUN1
depletion. The authors reasoned that the lacking Golgi-
accumulated SUN1 in HGPS cells was attributable to a
negative selection. Considering the loss-of-function ver-
sus gain-of-function model of lamin A proteins, theremight be a second possibility. Given that the proper
INM versus Golgi accumulation of SUN1 requires inter-
action with lamin A and increased binding capacity of
SUN1 to farnesylated prelamin A, it is plausible to
speculate that whereas loss of function of lamin A in
Lmna−/− (loss of full-length lamin A), LmnaΔ9 (loss of
exon 9 of lamin A) and HGPS (loss of 50 amino acids in
one allele of LMNA) upregulates the level of SUN1 but
loses the capacity to maintain its NE-anchorage; gain of
function of progerin (lamin AΔ50, gain of the farnesyl
C-tail) attracts more SUN1 to the NE and leads to nu-
cleus herniation. There could be a balance between loss
and gain of function of progerin, and it would be worth-
while to examine if FTIs could remove SUN1 from the
NE and whether this underlies the rescuing effect of
FTIs in HGPS. To further test this hypothesis, it would
be of interest to determine the level of Sun1 in
Zmpste24−/− mice, as well as cells ectopically expres-
sing progerin. If this is true, one would expect no abnor-
mal Golgi-accumulation of SUN1 but increased NE-
associated Sun1 in Zmpste24 null mice due to the pres-
ence of prelamin A protein with a farnesyl C-tail. In fact,
it has been recently shown that, while both prelamin A
and progerin exhibited increased binding capacity to his-
tone H3 peptide in comparison with lamin A, probably
attributable to their gain of function, they showed differ-
ences in binding to H3K27 peptide [10]. On the other
hand, prelamin A and lamin A had similar binding cap-
acity to H3K27 peptide, whereas progerin had a reduced
binding capacity, possibly due to a loss of function. It
was proposed that these functional variations are likely
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prelamin A and progerin contain an extra farnesylated
and methylated C-terminal tail, the 50-amino-acids dele-
tion differentiates progerin from prelamin A.
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